AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $92,000 | -77.1% | 8,856 | -76.3% | 0.01% | -73.7% |
| Q2 2022 | $402,000 | +13.6% | 37,407 | 0.0% | 0.02% | +35.7% |
| Q1 2022 | $354,000 | -24.7% | 37,407 | -8.1% | 0.01% | -17.6% |
| Q4 2021 | $470,000 | -13.6% | 40,716 | -28.5% | 0.02% | 0.0% |
| Q3 2021 | $544,000 | -13.2% | 56,950 | -12.4% | 0.02% | +13.3% |
| Q2 2021 | $627,000 | -2.3% | 65,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $642,000 | -0.8% | 65,000 | +131.9% | 0.02% | +7.1% |
| Q4 2020 | $647,000 | +52.2% | 28,028 | -6.9% | 0.01% | +55.6% |
| Q3 2020 | $425,000 | -12.4% | 30,120 | -6.3% | 0.01% | -18.2% |
| Q2 2020 | $485,000 | +50.2% | 32,138 | -8.2% | 0.01% | +37.5% |
| Q1 2020 | $323,000 | -5.3% | 35,008 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $341,000 | +21.4% | 35,008 | 0.0% | 0.01% | +33.3% |
| Q3 2019 | $281,000 | – | 35,008 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |